Shuhei Fukunaga
11PUBLICATIONS
3CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (11)
Sort by Publication Date:
|Nov 20, 2025
MetALD Was an Independent Risk Factor for the Recurrence of Early Esophageal Squamous Cell Carcinoma After Endoscopic Resection: A Multicenter Cohort Study Using Directed Acyclic Graphs.Michita Mukasa, Shuhei Fukunaga, Tomoyuki Nakane
|Aug 23, 2025
MetALD Was a More Notable Independent Risk Factor for Reflux Esophagitis Than MASLD: A Multicenter Cohort Study Using Directed Acyclic Graphs.Hiroshi Tanaka, Shuhei Fukunaga, Michita Mukasa
|May 03, 2025
Metabolic dysfunction-associated steatotic liver disease is a risk factor for gallstones: A multicenter cohort study.Tomonori Cho, Shuhei Fukunaga, Daiki Ohzono
|Dec 29, 2023
Impact of metabolic dysfunction-associated fatty liver disease on the incidence of Helicobacter pylori-negative gastric cancer.Tomoyuki Nakane, Shuhei Fukunaga, Dan Nakano
|Oct 05, 2023
Impact of non-obese metabolic dysfunction-associated fatty liver disease on risk factors for the recurrence of esophageal squamous cell carcinoma treated with endoscopic submucosal dissection: A multicenter study.Shuhei Fukunaga, Michita Mukasa, Tomoyuki Nakane
|Aug 26, 2022
Effect of Direct-Acting Antiviral Agents on Gastroesophageal Varices in Patients with Hepatitis C Virus-Related Cirrhosis.Hiroshi Hisanaga, Hidetoshi Takedatsu, Keigo Emori
Pageof 2
